|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
61,650,000 |
Market
Cap: |
211.46(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.08 - $7.57 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 6.1 |
Insider 3/6 Months : 6.7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
25,000 |
25,000 |
25,000 |
Total Buy Value |
$0 |
$40,500 |
$40,500 |
$40,500 |
Total People Bought |
0 |
2 |
2 |
2 |
Total Buy Transactions |
0 |
2 |
2 |
2 |
Total Shares Sold |
0 |
0 |
10,000 |
10,000 |
Total Sell Value |
$0 |
$0 |
$64,950 |
$64,950 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
2 |
2 |
End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Demopulos Gregory A Md |
Chairman, CEO & President |
|
2023-11-17 |
4 |
B |
$1.68 |
$25,200 |
I/I |
15,000 |
123,945 |
1.99 |
95% |
|
Demopulos Peter A Md |
Director |
|
2023-11-15 |
4 |
B |
$1.53 |
$15,300 |
D/D |
10,000 |
208,516 |
2.39 |
126% |
|
Demopulos Gregory A Md |
Chairman, CEO & President |
|
2023-11-14 |
4 |
A |
$1.44 |
$36,000 |
I/I |
25,000 |
108,945 |
|
- |
|
Demopulos Gregory A Md |
Chairman, CEO & President |
|
2023-11-13 |
4 |
A |
$1.29 |
$48,375 |
I/I |
37,500 |
83,945 |
|
- |
|
Bumol Thomas F. |
Director |
|
2023-09-12 |
4 |
A |
$3.31 |
$33,100 |
I/I |
10,000 |
10,000 |
|
- |
|
Cable Thomas J. |
|
|
2023-05-22 |
4 |
S |
$6.53 |
$32,650 |
D/D |
(5,000) |
35,067 |
|
54% |
|
Cable Thomas J. |
|
|
2023-05-22 |
4 |
OE |
$5.30 |
$26,500 |
D/D |
5,000 |
40,067 |
|
- |
|
Hanish Arnold C |
|
|
2023-05-22 |
4 |
S |
$6.46 |
$32,300 |
D/D |
(5,000) |
0 |
|
54% |
|
Hanish Arnold C |
|
|
2023-05-22 |
4 |
OE |
$5.30 |
$26,500 |
D/D |
5,000 |
5,000 |
|
- |
|
Hanish Arnold C |
|
|
2021-09-08 |
4 |
OE |
$9.44 |
$94,400 |
I/I |
10,000 |
10,000 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-06-17 |
4 |
AS |
$14.90 |
$549,169 |
D/D |
(36,857) |
2,026,986 |
|
-58% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-06-17 |
4 |
OE |
$4.10 |
$151,114 |
D/D |
36,857 |
2,063,843 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-06-15 |
4 |
AS |
$15.02 |
$553,577 |
D/D |
(36,856) |
2,026,986 |
|
-57% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-06-15 |
4 |
OE |
$4.10 |
$151,110 |
D/D |
36,856 |
2,063,842 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-05-20 |
4 |
AS |
$14.96 |
$551,366 |
D/D |
(36,856) |
2,026,986 |
|
-11% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-05-20 |
4 |
OE |
$4.10 |
$151,110 |
D/D |
36,856 |
2,063,842 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-05-19 |
4 |
AS |
$17.07 |
$629,149 |
D/D |
(36,857) |
2,026,986 |
|
-19% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-05-19 |
4 |
OE |
$4.10 |
$151,114 |
D/D |
36,857 |
2,063,843 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-04-08 |
4 |
AS |
$17.76 |
$625,259 |
D/D |
(35,206) |
2,026,986 |
|
-17% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-04-08 |
4 |
OE |
$4.10 |
$144,345 |
D/D |
35,206 |
2,062,192 |
|
- |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-04-07 |
4 |
AS |
$17.91 |
$669,959 |
D/D |
(37,407) |
2,026,986 |
|
-18% |
|
Demopulos Gregory A Md |
CHAIRMAN, CEO & PRESIDENT |
|
2021-04-07 |
4 |
OE |
$4.10 |
$153,369 |
D/D |
37,407 |
2,064,393 |
|
- |
|
Demopulos Peter A Md |
|
|
2021-02-22 |
4 |
OE |
$4.53 |
$49,150 |
D/D |
10,000 |
198,516 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-22 |
4 |
AS |
$23.28 |
$188,568 |
D/D |
(8,100) |
14,000 |
|
-31% |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-22 |
4 |
OE |
$10.27 |
$83,187 |
D/D |
8,100 |
22,100 |
|
- |
|
163 Records found
|
|
Page 1 of 7 |
|
|